HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seelwan Sathitratanacheewin Selected Research

Rheumatic Diseases (Rheumatism)

5/2022Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study.
12/2021Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seelwan Sathitratanacheewin Research Topics

Disease

2Rheumatic Diseases (Rheumatism)
05/2022 - 12/2021
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 12/2021
2Rheumatoid Arthritis
05/2022 - 01/2022
2COVID-19
01/2022 - 12/2021
2Chronic Disease (Chronic Diseases)
01/2018 - 01/2018
1Migraine Disorders (Migraine)
01/2023
1Heart Arrest (Cardiac Arrest)
12/2020
1Neoplasms (Cancer)
10/2020

Drug/Important Bio-Agent (IBA)

2COVID-19 VaccinesIBA
05/2022 - 12/2021
1galcanezumabIBA
01/2023
1Monoclonal AntibodiesIBA
01/2023
1mRNA VaccinesIBA
05/2022
1BNT162 VaccineIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1sinovac COVID-19 vaccineIBA
12/2021
1VaccinesIBA
12/2021
1Inactivated VaccinesIBA
12/2021
1Anti-Bacterial Agents (Antibiotics)IBA
12/2020
1VS 215IBA
10/2020

Therapy/Procedure

2Palliative Care (Palliative Therapy)
01/2018 - 01/2018
1Injections
01/2023